1
Tacrolimus Treatment for Refractory Autoimmune Cytopenia
Condition(s):Autoimmune Hemolytic Anemia; Pure Red Cell Aplasia; Evans SyndromeLast Updated:December 3, 2019Recruiting
Tacrolimus: 1448 Clinical Trials, Page 1 of 145
Hide Studies Not Open or Pending
2
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Condition(s):Transplant;Failure,KidneyLast Updated:February 15, 2019Not yet recruiting
3
OPTImization of the Dose of tacroliMUS by Bayesian Prediction
Condition(s):KIDNEY TRANSPLANTATIONLast Updated:March 14, 2018Recruiting
4
Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells
Condition(s):HemochromatosisLast Updated:September 4, 2018Completed
5
Tacrolimus Treatment for Refractory PRCA
Condition(s):Pure Red Cell AplasiaLast Updated:May 30, 2018Recruiting
6
Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome
Condition(s):Nephrotic Syndrome; Tacrolimus; PharmacokineticsLast Updated:August 5, 2019Not yet recruiting
7
Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome
Condition(s):Dry Eye; Sjogren SyndromeLast Updated:May 22, 2019Completed
8
A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients
Condition(s):Kidney TransplantationLast Updated:November 7, 2018Completed
9
Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors
Condition(s):Evidence of Liver Transplantation; Effects of Immunosuppressant TherapyLast Updated:October 12, 2016Completed
10
Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation
Condition(s):Renal Transplant Rejection; Kidney Transplant Failure and RejectionLast Updated:January 31, 2019Recruiting